Lorven Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2011.
2011 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Lorven Pharmaceuticals Private Limited

Lorven Pharmaceuticals Private Limited, a active private limited company, was established on 11 March 2011 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U36912TN2011PTC079598. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹3.00 Cr.

Formerly known as Seagull Health Care Private Limited. It upholds a compliant status. Its leadership includes Seenivasan Vignesh (Director), Valliappan (Director). Past directors included Durga Maha Lakshmi Gedela, Govindaraajan Renuka, Venkatramanjulu Ramamurthy. It holds ₹9.00 M open charges and ₹1.89 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.63, 1St Floor, 5Th Block Mogappair West, Nolambur, Chennai, Tamil Nadu, 600037.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U36912TN2011PTC079598

  • Registration Number

    079598

  • Incorporation Date

    11 March 2011

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹3.00 Cr

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 3.00 Cr
  • Company Age 14 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 9.00 M
  • Satisfied Charges ₹ 1.89 Cr
  • Revenue Growth **** -31.90%
  • Profit Growth **** -143.84%
  • Ebitda **** 12.22%
  • Net Worth -9.03%
  • Total Assets **** 0.17%
Company report

Lorven Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Lorven Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Lorven Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Seenivasan Vignesh Director 23 Feb 2025 Current
Valliappan Director 23 Feb 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 02 Mar 2021 Past
Pramod Abcsdd Additional Director 29 Sep 2014 Past
Pramod Abcsdd Director 20 Jun 2017 Past
Pramod Abcsdd Director 20 Jun 2017 Past
Pramod Abcsdd Additional Director 29 Sep 2014 Past
Pramod Abcsdd Director 14 Mar 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Lorven Pharmaceuticals.

Lorven Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 31.9% decrease. The company also saw a substantial fall in profitability, with a 143.84% decrease in profit. The company's net worth dipped by a decrease of 9.03%.

Lorven Pharmaceuticals revenue growth over time
Lorven Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -31.90%
*******
*******
*******
*******
Revenue from Operations
*******
 -31.30%
*******
*******
*******
*******
Total Assets
*******
 0.17%
*******
*******
*******
*******
Profit or Loss
*******
 -143.84%
*******
*******
*******
*******
Net Worth
*******
 -9.03%
*******
*******
*******
*******
EBITDA
*******
 12.22%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Lorven Pharmaceuticals?

In 2022, Lorven Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹9,000,000.00

Satisfied Charges

₹18,880,000.00

Charges Breakdown by Lending Institutions
  • Others : 0.90 Cr
Latest Charge Details
Date Lender Amount Status
16 Nov 2019 Others ₹9.00 M Open
08 Jun 2016 Tamilnad Mercantile Bank Limited ₹9.13 M Satisfied
09 May 2015 Tamilnad Mercantile Bank Limited ₹9.75 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Lorven Pharmaceuticals?

Unlock and access historical data on people associated with Lorven Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Lorven Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lorven Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Lorven Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Seenivasan Vignesh was appointed as a Director was appointed as a Director on 23 Feb 2025 & has been associated with this company since 1 year 7 days . was documented.

  • Director Appointment

    The activity Valliappan was appointed as a Director was appointed as a Director on 23 Feb 2025 & has been associated with this company since 1 year 7 days . was completed.

  • Annual General Meeting

    The activity Lorven Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Lorven Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.

  • Charges

    Progress on A charge registered on 08 Jun 2016 via Charge ID 100035988 with Tamilnad Mercantile Bank Limited was fully satisfied on 03 Jan 2022. was documented.

  • Charges

    The activity A charge registered on 09 May 2015 via Charge ID 10568322 with Tamilnad Mercantile Bank Limited was fully satisfied on 03 Jan 2022. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Lorven Pharmaceuticals Private Limited?

The CIN of Lorven Pharmaceuticals Private Limited is U36912TN2011PTC079598.

Where is Lorven Pharmaceuticals Private Limited headquartered?

Lorven Pharmaceuticals Private Limited is headquartered at No.63, 1St Floor, 5Th Block Mogappair West, Nolambur, Chennai, Tamil Nadu, 600037.

When was Lorven Pharmaceuticals Private Limited incorporated?

Lorven Pharmaceuticals Private Limited was incorporated on 11 March 2011.

Who are the current directors of Lorven Pharmaceuticals Private Limited?

The current directors of Lorven Pharmaceuticals Private Limited are

What is the primary industry of Lorven Pharmaceuticals Private Limited?

The primary industry of Lorven Pharmaceuticals Private Limited is Manufacturing.

Is Lorven Pharmaceuticals Private Limited a listed company?

Lorven Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Lorven Pharmaceuticals Private Limited?

The authorized capital of Lorven Pharmaceuticals Private Limited is ₹3.00 Cr, and the paid-up capital is ₹3.00 Cr.

What is the compliance status of Lorven Pharmaceuticals Private Limited?

The compliance status of Lorven Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available